Septerna, Inc. Common Stock
SEPNSepterna, Inc. is a biotechnology company focused on developing innovative therapies targeting G protein-coupled receptors (GPCRs) to address unmet medical needs. The company leverages advanced research and proprietary technology platforms to discover and advance novel drugs in areas such as neuroscience, immunology, and metabolic diseases.
$26.71 -0.04 (-0.13%)
Company News
Septerna to Participate in 8th Annual Evercore Healthcare Conference
Septerna, a clinical-stage biotechnology company specializing in GPCR drug discovery, will participate in the 8th Annual Evercore Healthcare Conference on December 2, 2025, presenting via live webcast.
Analysts Think These Stocks Could More Than Double in Value
Analysts believe three healthcare stocks - Septerna Inc, Intellia Therapeutics, and Novavax - have the potential to at least double in price, although they carry varying levels of risk.
